SAN
DIEGO, March 28, 2024
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a
commercial-stage biotechnology company, today announced that
Craig Collard, Chief Executive
Officer of Heron, will participate in a fireside chat on
Wednesday, April 10, 2024, at
11:00 AM ET at the
23rd Annual Needham Virtual Healthcare
Conference. The conference is being held in a virtual
format, April 8-11, 2024.
A live webcast of the fireside chat will be available on the
Company's website at www.herontx.com in the Investor
Resources section.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology
company focused on improving the lives of patients by developing
and commercializing therapeutic innovations that improve medical
care. Our advanced science, patented technologies, and innovative
approach to drug discovery and development have allowed us to
create and commercialize a portfolio of products that aim to
advance the standard-of-care for acute care and oncology patients.
For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as
defined by the Private Securities Litigation Reform Act of 1995.
Heron cautions readers that forward-looking statements are based on
management's expectations and assumptions as of the date of this
news release and are subject to certain risks and uncertainties
that could cause actual results to differ materially. These risks
and uncertainties include, but are not limited to, risks and
uncertainties identified in the company's filings with the
Securities and Exchange Commission. Forward-looking statements
reflect our analysis only on their stated date, and Heron takes no
obligation to update or revise these statements except as may be
required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-announces-presentation-at-the-23rd-annual-needham-virtual-healthcare-conference-302103058.html
SOURCE Heron Therapeutics, Inc.